The following represents disclosure information provided by authors of this abstract. The ASCO Scientific Program Committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered self-held and compensated unless otherwise noted. Employment/Leadership relationships are considered compensated employment unless otherwise noted. L = Leadership, U = Uncompensated, I = Immediate Family Member, B = Both Myself and Immediate Family Member, Inst = My Institution
Treatment patterns and cost for colorectal cancer by line of therapy and metastasis status.
Brian S. Seal
Employment or Leadership Position - Bayer (I)
Charles Kreilick
Employment or Leadership Position - Bayer
Susan H. Boklage
Employment or Leadership Position - Bayer
Kenneth M. Shermock
Consultant or Advisory Role - Bayer
Honoraria - Bayer
Carl V Asche
Consultant or Advisory Role - Bayer
Honoraria - Bayer